Home Your basket
• Choanal atresia: therapeu...
   Price 10.50 €
• Usefulness and limitation...
   Price 10.50 €
• Pyogenic granuloma of the...
   Price 8.50 €
• Petrosal presigmoid appro...
   Price 8.50 €
• Middle ear tuberculosis e...
   Price 5.50 €
• Acoustic study of sustain...
   Price 10.50 €
• Adenoid cystic carcinoma ...
   Price 5.50 €
• The lymphoepithelial carc...
   Price 5.50 €
• A single appointment with...
   Price 8.50 €
• Botulinum toxin, descript...
   Price 12.50 €
• Non-functioning parathyro...
   Price 5.50 €
• Extramuscular soft tissue...
   Price 8.50 €
• Nasal involvement in Croh...
   Price 10.50 €
• These lesions of the voca...
   Price 10.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Evaluation of the handica...
   Price 10.50 €
• Reconstruction after tumo...
   Price 10.50 €
• Chyle leak after cervical...
   Price 15.00 €
• Liposarcoma of the hypoph...
   Price 5.50 €
• From barotrauma otitis to...
   Price 8.50 €
• Covering of parotid and c...
   Price 14.00 €
• Late metastasis from rena...
   Price 8.50 €
• Endoscopic anatomy of the...
   Price 10.50 €
• Cleft palate and otitis m...
   Price 10.50 €
• Middle ear osteoma: A rar...
   Price 8.50 €
• Management of cervical ly...
   Price 10.50 €
• Prognostic value of senti...
   Price 10.50 €
• Interest of the chest CT ...
   Price 10.50 €
• Parry-Romberg syndrome as...
   Price 12.50 €
• Congenital absence of the...
   Price 8.50 €
• Therapeutic choices for c...
   Price 8.50 €
• Adenoid cystic carcinoma ...
   Price 5.50 €
• Dysphonia in children: Re...
   Price 12.50 €
• The complications of end...
   Price 8.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Progressive cochleo-vesti...
   Price 5.50 €

Total Order 330.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2007 o

RHINOLOGY

Efficacy and safety of mometasone furoate nasal spray in the treatment of sinusitis or acute rhinosinusitis


Authors : Klossek J. M (Poitiers)

Ref. : Rev Laryngol Otol Rhinol. 2007;128,3:187-192.

Article published in french
Downloadable PDF document french



Summary : Sinusitis or acute rhinosinusitis, is defined as an acute viral or bacterial infection characterised by inflammation of the mucosa of the nose and paranasal sinuses. Although antibiotics are routinely prescribed for the treatment of acute sinusitis, most cases are caused by viral infections and will resolve without antibiotic therapy. Given concerns about global antibacterial resistance, evidence-based clinical practice guidelines recommend a conservative approach to antibiotic treatment, with mild or moderately severe acute sinusitis managed symptomatically. Intranasal corticosteroids act on the nasal mucosa to relieve inflammation and its associated symptoms, and may be a useful symptomatic treatment option. Two randomised, placebo-controlled trials have demonstrated that the corticosteroid mometasone furoate, administered as a nasal spray (MFNS), is effective as an adjunct to antibiotics in acute sinusitis. The design of these studies show a therapeutic approach known in Europe, but this attitude is still different from the current French guidelines. Furthermore, the efficacy and safety of MFNS monotherapy has been compared with antibiotic therapy in a randomised, double-blind, placebo-controlled trial in adults with acute uncomplicated sinusitis and probably viral. In this study, twice-daily (BID) MFNS 200 µg produced statistically greater improvements in overall symptoms and most individual symptoms compared with amoxicillin or placebo, even though Amoxicillin is not the one recommended by the French guidelines for this indication. These findings suggest that MFNS may play an important role in the management of acute sinusitis, either as monotherapy or as adjunctive treatment to antibiotics. These results lead also to think over its interest in the treatment of uncomplicated common forms of sinusitis, where antibiotics are still widely prescribed in daily practice.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE